Development of a CNN for Adult Brain Tumour Characterisation: Implications and Future Directions for Transfer Learning.

Brain tumours are the most commonly occurring solid tumours in children, albeit with lower incidence rates compared to adults. However, their inherent heterogeneity, ethical considerations regarding paediatric patients, and difficulty in long-term follow-up make it challenging to gather large homogenous datasets for analysis. This study focuses on the development of a Convolutional Neural Network (CNN) for brain tumour characterisation using the adult BraTS 2020 dataset. We propose to transfer knowledge, from models pre-trained on extensive adult brain tumour datasets to smaller cohort datasets (e.g., paediatric brain tumours) in future studies, by leveraging Transfer Learning (TL). This approach aims to extract relevant features from pre-trained models, addressing the limited availability of annotated paediatric datasets and enhancing tumour characterisation in children. The implications and potential applications of this methodology in paediatric neuro-oncology are discussed.

Deep Learning-Based Synthetic Skin Lesion Image Classification.

Advances in general-purpose computers have enabled the generation of high-quality synthetic medical images that human eyes cannot differ between real and AI-generated images. To analyse the efficacy of the generated medical images, this study proposed a modified VGG16-based algorithm to recognise AI-generated medical images. Initially, 10,000 synthetic medical skin lesion images were generated using a Generative Adversarial Network (GAN), providing a set of images for comparison to real images. Then, an enhanced VGG16-based algorithm has been developed to classify real images vs AI-generated images. Following hyperparameters tuning and training, the optimal approach can classify the images with 99.82% accuracy. Multiple other evaluations have been used to evaluate the efficacy of the proposed network. The complete dataset used in this study is available online to the research community for future research.

How Interoperability Challenges Are Addressed in Healthcare IoT Projects.

The rapid development and implementation of Internet of Medical Things has made interoperability a serious challenge. In this scoping review, we provide an overview of the interoperability challenge, as reported in the health literature, and highlight the proposed solutions. After searching between January 2018 and June 2023 in Compendex via Engineering Village and PubMed, we found 18 publications. The interoperability challenges identified were device heterogeneity, system heterogeneity, data standardization, security and safety, system and architecture standard, system and workflow integration and regulatory and compliance requirements. Solutions included ontology approaches, conceptual semantic frameworks, improved standards, design of middleware, and using blockchain technology.

Clinical Decision Support Systems for Brain Tumour Diagnosis and Prognosis: A Systematic Review.

CDSSs are being continuously developed and integrated into routine clinical practice as they assist clinicians and radiologists in dealing with an enormous amount of medical data, reduce clinical errors, and improve diagnostic capabilities. They assist detection, classification, and grading of brain tumours as well as alert physicians of treatment change plans. The aim of this systematic review is to identify various CDSSs that are used in brain tumour diagnosis and prognosis and rely on data captured by any imaging modality. Based on the 2020 preferred reporting items for systematic reviews and meta-analyses (PRISMA) protocol, the literature search was conducted in PubMed and Engineering Village Compendex databases. Different types of CDSSs identified through this review include Curiam BT, FASMA, MIROR, HealthAgents, and INTERPRET, among others. This review also examines various CDSS tool types, system features, techniques, accuracy, and outcomes, to provide the latest evidence available in the field of neuro-oncology. An overview of such CDSSs used to support clinical decision-making in the management and treatment of brain tumours, along with their benefits, challenges, and future perspectives has been provided. Although a CDSS improves diagnostic capabilities and healthcare delivery, there is lack of specific evidence to support these claims. The absence of empirical data slows down both user acceptance and evaluation of the actual impact of CDSS on brain tumour management. Instead of emphasizing the advantages of implementing CDSS, it is important to address its potential drawbacks and ethical implications. By doing so, it can promote the responsible use of CDSS and facilitate its faster adoption in clinical settings.

A systematic review considering risk factors for mortality of patients discharged from hospital with a diagnosis of diabetes.

AIM: To identify known risk factors for mortality for adult patients, discharged from hospital with diabetes. METHOD: The systematic review was based on the PRISMA protocol. Studies were identified through EMBASE & MEDLINE databases. The inclusion criteria were papers that were published over the last 6 years, in English language, and focused on risk factors of mortality in adult patients with diabetes, after they were discharged from hospitals. This was followed by data extraction "with quality assessment and semi-quantitative synthesis according to PRISMA guidelines". RESULTS: There were 35 studies identified, considering risk factors relating to mortality for patients, discharged from hospital with diabetes. These studies are distributed internationally. 48 distinct statistically significant risk factors for mortality can be identified. Risk factors can be grouped into the following categories; demographic, socioeconomic, lifestyle, patient medical, inpatient stay, medication related, laboratory results, and gylcaemic status. These risk factors can be further divided into risk factors identified in generalized populations of patients with diabetes, compared to specific sub-populations of people with diabetes. CONCLUSION: A relatively small number of studies have considered risk factors relating to mortality for patients, discharged from hospital with a diagnosis of diabetes. Mortality is an important outcome, when considering discharge from hospital with diabetes. However, there has only been limited consideration within the research literature.